×

Compositions and methods for treating or preventing diseases associated with oxidative stress

  • US 9,566,301 B2
  • Filed: 03/28/2013
  • Issued: 02/14/2017
  • Est. Priority Date: 03/29/2012
  • Status: Active Grant
First Claim
Patent Images

1. A stable pharmaceutical composition for use in corneal collagen cross-linking, comprising (a) between about 0.015% to about 5% sodium iodide by weight, (b) riboflavin, and (c) a pharmaceutically-acceptable excipient appropriate for ocular administration, wherein the pharmaceutical composition maintains a basic pH that permits iodide ion to catalytically break hydrogen peroxide into water and oxygen.

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×